Synergy CHC Corp

Synergy CHC Corp(SNYR)股票分析

$0.091

-0.061 (-67.02%)收盤時

Loading chart…
最高
0.157
開盤
0.137
成交量加權均價
0.11
成交量
70.12M
市值
—
最低
0.091
成交金額
7.90M
企業價值/稅息折舊攤銷前利潤(TTM)
-8.03

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

AI 分析 of Synergy CHC Corp (SNYR)

賣出

Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.

估值指標

Synergy CHC Corp(SNYR)目前預期本益比為 1.83,5 年平均預期本益比為 1.51。

預期本益比

合理
5 年均值 P/E
1.51
目前P/E
1.83
高估
3.81
低估
-0.79

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
1.43
目前EV/EBITDA
-8.03
高估
6.47
低估
-3.62

預期股價營收比

低估
5 年均值 P/S
0.34
目前P/S
0.04
高估
0.59
低估
0.09

事件時間軸

2026-08-21 (ET)

09:00:00

Synergy CHC Receives Compliance Notice from Nasdaq

2026-05-15 (ET)

17:10:00

Synergy CHC Files to Sell 101.71M Shares of Common Stock

2026-04-01 (ET)

09:20:00

Company Q4 Revenue Falls to $6.07M

2026-01-27 (ET)

08:10:00

Synergy CHC Expands FOCUSfactor Product Line in Canada

2025-12-16 (ET)

08:10:00

Synergy CHC Appoints Pedro Colmenares as Sales & Marketing Director for Mexico & Latin America

資訊

SNYR 常見問題 —— 由 Alphio AI 解答

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications. It operates in the Healthcare sector.

Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易